Anavex Life Sciences Corp (AVXL)

[nidan7500]

"March 9, 2023 07:18 AM EST R&DPharma
Ten years later, Lilly's long-term Alzheimer's trial of solanezumab has definitively failed
Drew Armstrong
Executive Editor
A trial of Eli Lilly’s Alzheimer’s drug solanezumab that began in 2013 didn’t show any benefit in patients, who were followed for a decade to try and answer whether the amyloid-targeting drug might slow the disease.

Is this just another dead Amyloid Mule along the AD trail? Anyone looking for a miracle needs to go look at Anavex...